Search results for: 'partnering agreements with next therapeutic 2025 2020'
- Related search terms
- partnering agreements with optimer pharmaceuticals 2025 2020
- partnering agreements with optimer pharmaceuticals 2025 2025
- partnering agreements with regeneron pharmaceutical 2025 2010
- partnering agreements with aptam pharmaceuticals 2025 2016
- partnering agreements with biogen innov 2016 2025
-
Viral Vector Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2025
Learn More -
Metagenomics Market: Global Market Analysis with Forecasts by Application, Technology, Product and User with Executive and Consultant Guides 2025 to 2029January 2025$6,995.00Metagenomics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Gene Editing Markets by Application, Technology, Place, Industry and Product with Executive and Consultant Guides 2025 to 2029January 2025$6,995.00Gene Editing Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025July 2025$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2025April 2025$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Licensing Deals in Pharmaceuticals 2019-2025July 2025$4,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2025March 2025$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025March 2025$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Medical Device Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Medical Device Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
